Materials • Major Chemicals
$10.24 ▲ +0.05
(+0.49%)
MKT CAP: $1.12B • VOL: 1.32M
52W L $7 52W H $15
ECVT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $723.5M | $598.3M | $584.8M |
| YoY Revenue Growth % | +20.9% | +2.3% | — |
| Gross Profit | $158.1M | $163.4M | — |
| Gross Margin % | 21.8% | 27.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $64.9M | $85.1M | $89.6M |
| Operating Margin % | 9.0% | 14.2% | 15.3% |
| Net Income (GAAP) | -$71.1M | -$6.7M | $71.2M |
| EBITDA (Normalized) | $121.2M | $129.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $140.3M | $149.9M | $137.6M |
| Capital Expenditures (CapEx) | $70.4M | $55.6M | — |
| Free Cash Flow (FCF) | $69.9M | $94.3M | $137.6M |
| FCF Margin % | 9.7% | 15.8% | 23.5% |
| Return on Invested Capital (ROIC %) | 6.4% | 4.7% | — |
| Cash & Short-Term Equivalents | $197.2M | $131.4M | — |
| Total Debt (Short + Long Term) | $392.6M | $852.1M | — |
| Total Stockholders' Equity | $603.4M | $700.5M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ECVT.